Related Experiment Video
Updated: Oct 18, 2025
08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.5K
The second modification of a dedicated staging system for lung metastases
Michel Gonzalez1, Marcello Migliore2,3
1Thoracic Surgery, Centre Hospitalier Universitaire Vaudois-1011, Lausanne, Switzerland.
Future Oncology (London, England)
|September 29, 2021
Summary
A new pmTNM classification system for pulmonary metastases is proposed to identify patients who benefit from lung metastasectomy. This system aims to improve survival predictions and standardize communication for lung metastasis treatment.
Area of Science:
- Oncology
- Thoracic Surgery
- Pulmonary Medicine
Background:
- Pulmonary metastases are a significant clinical challenge with ongoing debate regarding surgical resection benefits.
- Identifying patients who will survive curative resection for lung metastases remains unclear.
Purpose of the Study:
- To update and propose a standardized pmTNM classification system for pulmonary metastases.
- To facilitate research into predictive and prognostic factors for lung metastasis survival.
- To differentiate patients who will benefit from lung metastasectomy from those who will not.
Main Methods:
- The study proposes an updated classification system for pulmonary metastases, termed pmTNM.
- This system is analogous to the established TNM classification for primary tumors.
Main Results:
- The proposed pmTNM classification aims to standardize the assessment of pulmonary metastases.
- It provides a framework for future studies on prognostic factors and treatment outcomes.
Conclusions:
- The updated pmTNM classification system is crucial for advancing the understanding and treatment of pulmonary metastases.
- It will enable consistent data comparison and improved patient selection for lung metastasectomy.
